Awardee OrganizationUNIVERSITY OF CALIFORNIA BERKELEY
Description
Abstract Text
It has been long been known that eukaryotic ribosomes are heterogeneous in nature. Ribosome
heterogeneity is exemplified by the differential presence of certain ribosomal proteins and ribosomal
RNAs, modification of ribosomal proteins and RNA, and association of non-ribosomal proteins with
ribosomal particles. However, it remains unknown whether the heterogeneous pools of ribosomes reflect
distinct activities in protein biosynthesis. More recently, it has become clear that the internal ribosome
entry sites (IRES) located in certain viral mRNAs can bind directly and with high affinity to mammalian
40S subunits. The aims of this proposal are to examine whether functionally heterogeneous populations
of ribosomes exist in mammalian cells and whether distinct ribosome populations are recruited to
picornaviral and hepatitis C viral IRES elements in infected cells. In the first aim, the composition and
activity of total, unbound and polysome-bound ribosomal subunits from uninfected cells will be compared
to those isolated from picornavirus infected cells by electrospray mass spectrometry (ES-MS). In the
second aim, the presence of altered ribosomes in viral mRNA-complexes will be examined. Specifically,
thiouridine-containing viral RNA will be generated in HeLa cells expressing the Toxoplasma gondii uracil
phosphoribosyltransferase (UPRT) enzyme. UPRT will convert thiouracil to thiouridine 5' monophosphate
nucleotides whose triphosphates can be selectively incorporated into viral RNA by the viral RNAdependent
RNA polymerase in the presence of actinomycin D. Polysomal thio-labeled RNA will be
biotinylated, isolated by streptavidin chromatography and associated ribosomes characterized by ES-MS.
This method will also be used to identify IRES-binding proteins that are tightly linked to the viral RNA in
infected cells. Finally, the roles of modified ribosomes in various steps of translation initiation will be
examined in reconstituted translation systems. The outcome from these studies will reveal roles of
modified ribosomes in mammalian cells and will provide insights by which IRES elements recruit host cell
ribosomes during viral infection, revealing new potential targets for antiviral therapeutics.
No Sub Projects information available for 1P01GM073732-01A1 0004
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P01GM073732-01A1 0004
Patents
No Patents information available for 1P01GM073732-01A1 0004
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P01GM073732-01A1 0004
Clinical Studies
No Clinical Studies information available for 1P01GM073732-01A1 0004
News and More
Related News Releases
No news release information available for 1P01GM073732-01A1 0004
History
No Historical information available for 1P01GM073732-01A1 0004
Similar Projects
No Similar Projects information available for 1P01GM073732-01A1 0004